Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 22 2013
Print RSS Feed

Breaking News

Gil Roth
April 11, 2013
Roche 1Q13 1Q Revenues: $12.5 billion (+4%) 1Q Earnings: not disclosed Comments: Pharma revenues overall rose 5% to $9.9 billion, with U.S. sales up 13% to $4.2 billion, European sales up 1% to $2.5 billion, Japanese sales down 12% to $888 million…  Read More »

April 11, 2013
Dalton to synthesize and manufacture selected drug candidates  Read More »

April 11, 2013
Pellet formulations support API effectiveness  Read More »

April 11, 2013
Dinkelacker, Duffield bring extensive experience  Read More »

April 10, 2013
Adds drug safety services  Read More »

April 10, 2013
Takes minority equity stake in Redwood Bioscience  Read More »

April 10, 2013
DeSeabra brings 20 years of leadership experience  Read More »

April 10, 2013
To supply customized EZMix dual-chamber syringe in 15-year deal  Read More »

April 10, 2013
Adds Anticalin program  Read More »

April 9, 2013
Jackle to oversee U.S.-based clinical trials  Read More »

April 9, 2013
Darienzo brings 30 years of experience  Read More »

April 9, 2013
Expands global presence in outsourced clinical services  Read More »

April 9, 2013
Acquires rights to Tykerb in China  Read More »

April 9, 2013
Will use iBioLaunch for Bio-Manguinhos/Fiocruz facility in Brazil  Read More »

April 8, 2013
Sigal to retire June 30  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On